NSEUpdates2 Jul 2026 · 2 Jul 2026, 04:21 pm
Updates
Onesource Specialty Pharma Limited · ONESOURCE
✦ AI SummaryRegulatory
OneSource Specialty Pharma Limited has informed the Exchange regarding the completion of a US-FDA inspection at its Sterile Product Division facility in Bengaluru, with one observation noted and a comprehensive response to be submitted within the stipulated time frame.
Analysis Scores
Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk6/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
Full Announcement
Onesource Specialty Pharma Limited has informed the Exchange regarding 'Completion of US-FDA Inspection at Sterile Product Division facility at Bengaluru'.